Psychedelic: Difference between revisions
>Unity Expanded introduction. |
>Unity Overhauled toxicity section; various miscellanea |
||
Line 1: | Line 1: | ||
[[File:Oversoul by Alex Grey.jpg|300px|thumb|right|''Oversoul'' by '''[http://alexgrey.com/art/paintings/soul/oversoul/ Alex Grey]''' - An example of [[psychedelic]] artwork created by the renowned visionary artist Alex Grey. This image is a representation of an experience report found in the 1901 book [http://en.wikipedia.org/wiki/Cosmic_Consciousness ''Cosmic Consciousness''] ]] | [[File:Oversoul by Alex Grey.jpg|300px|thumb|right|''Oversoul'' by '''[http://alexgrey.com/art/paintings/soul/oversoul/ Alex Grey]''' - An example of [[psychedelic]] artwork created by the renowned visionary artist Alex Grey. This image is a representation of an experience report found in the 1901 book [http://en.wikipedia.org/wiki/Cosmic_Consciousness ''Cosmic Consciousness''] ]] | ||
'''Psychedelics''' (also known as '''[[serotonergic]] [[hallucinogens]]''') are a class of [[psychoactive substances]] that produce an altered state of consciousness marked by unusual changes in perception, mood, and cognitive processes.<ref name="nicholsPSY>Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264-355. https://doi.org/10.1124/pr.115.011478</ref> While their precise mechanism is not | '''Psychedelics''' (also known as '''[[serotonergic]] [[hallucinogens]]''') are a class of [[psychoactive substances]] that produce an altered state of consciousness marked by unusual changes in perception, mood, and cognitive processes.<ref name="nicholsPSY>Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264-355. https://doi.org/10.1124/pr.115.011478</ref> While their precise mechanism of action is not known, psychedelics are thought to produce their characteristic effects by binding to [[serotonin]] [[receptors]] ('''5'''-'''h'''ydroxy'''t'''ryptamine or '''5-HT'''), particularly the 5-HT<sub>2a</sub> subtype. Serotonin plays a number of critical roles throughout the human body and is a key [[neurotransmitter]] involved in the functioning and regulation of sensory perception, behavior, mood, cognition and memory.<ref name=nichols5HT>Nichols, D. E., & Nichols, C. D. (2008). Serotonin Receptors. Chemical Reviews, 108(5), 1614-1641. https://doi.org/10.1021/cr078224o</ref> | ||
Human usage of psychedelics predates written history, and there is growing evidence that they were employed by early cultures in a variety of sociocultural and ritual contexts.<ref name="nicholsPSY /> In modern times, psychedelic substances are used for a number of purposes that span from the traditional shamanic forms (such as the use of [[ayahuasca]] in the Amazon jungle, or [[peyote]] among Native Americans) to more modern forms of New Age spiritual, [[transpersonal]], or religious practices. Psychedelics, particularly those in the traditional or herbal forms, are sometimes referred to as [[entheogens]] (i.e. "generating the divine within")<ref>Dictionary - Entheogen | http://dictionary.reference.com/browse/entheogen</ref> by those who use them for these purposes, although they are also often used in purely [[recreational drug use|recreational settings]]. | |||
[[Subjective effects]] can vary significantly depending on class, but generally include some form of [[geometry|open and closed-eye visuals]], [[time distortion]], [[introspection|enhanced introspection]], [[conceptual thinking]], [[euphoria]], and [[ego loss]]. The so-called classical psychedelics, which consist of [[LSD]], [[psilocybin mushrooms]], [[mescaline]], and [[DMT]] ([[ayahuasca]]) are considered to produce the archetypal psychedelic effects and also have the | [[Subjective effects]] can vary significantly depending on class, but generally include some form of [[geometry|open and closed-eye visuals]], [[time distortion]], [[introspection|enhanced introspection]], [[conceptual thinking]], [[euphoria]], and [[ego loss]]. The so-called classical psychedelics, which consist of [[LSD]], [[psilocybin mushrooms]], [[mescaline]], and [[DMT]] ([[ayahuasca]]) are considered to produce the archetypal psychedelic effects and also have the most established safety profiles. Psychedelics can be divided into three major sub-classes: [[tryptamines]], [[lysergamides]], and [[phenethylamines]]. Psychedelic tryptamines are based on, or derive from, [[dimethyltryptamine]] (DMT), lyergamides on [[LSD]], and phenethylamines on [[mescaline]]. | ||
Unlike other highly prohibited substances, most psychedelics have not been shown to be physiologically toxic | Unlike other highly prohibited substances, most psychedelics have not been shown to be physiologically toxic and none have been shown to be addictive.<ref name="nicholsPSY /> However, adverse psychological reactions such as severe [[anxiety]], [[paranoia]], [[delusions]], and [[psychosis]] are always possible, particularly for those predisposed to mental disorders.<ref>{{cite journal|last=Strassmann|first=Rick|title=Adverse reactions to psychedelic drugs. A review of the literature|journal=Journal of Nervous and Mental Disease|volume=172|issue=10|pages=577–595|doi=10.1097/00005053-198410000-00001|pmid=6384428|year=1984|issn=0022-3018|oclc=1754691}}</ref> As a result, it is highly advised to use [[Harm reduction#Hallucinogens|harm reduction practices]] if using these substances. | ||
==Etymology== | ==Etymology== | ||
The term "psychedelic" was coined by psychiatrist Humphry Osmond in 1956 as an alternative descriptor for [[ | The term "psychedelic" was coined by psychiatrist Humphry Osmond in 1956 as an alternative descriptor for [[hallucinogens]] in the context of psychedelic psychotherapy.<ref>Nicholas Murray, ''Aldous Huxley: A Biography'', 419.</ref> Seeking a name for the experience induced by [[LSD]], Osmond contacted [[Aldous Huxley]], a personal acquaintance and advocate for the therapeutic use of the substance. Huxley coined the term "phanerothyme," from the Greek terms for "manifest" (φανερός) and "spirit" (θύμος). | ||
In a letter to Osmond, he wrote: | |||
{{quote| | {{quote| | ||
To make this mundane world sublime,<br | To make this mundane world sublime,</br> | ||
Take half a gram of phanerothyme}} | Take half a gram of phanerothyme}} | ||
Line 18: | Line 20: | ||
{{quote| | {{quote| | ||
To fathom Hell or soar angelic,<br> | To fathom Hell or soar angelic,</br> | ||
Just take a pinch of psychedelic<ref>Tanne, J. H. (2004). Humphry Osmond. BMJ: British Medical Journal, 328(7441), 713. https://doi.org/10.1136/bmj.328.7441.713</ref> | Just take a pinch of psychedelic<ref>Tanne, J. H. (2004). Humphry Osmond. BMJ: British Medical Journal, 328(7441), 713. https://doi.org/10.1136/bmj.328.7441.713</ref>}} | ||
}} | |||
"Psychedelic" derives from the Greek words ''ψυχή'' (psyche, "soul, mind") and ''δηλείν'' (delein, "to manifest") which taken together mean "soul-manifesting | "Psychedelic" derives from the Greek words ''ψυχή'' (psyche, "soul, mind") and ''δηλείν'' (delein, "to manifest") which taken together mean "soul-manifesting." The implication was that psychedelics can allow one to access the soul and develop unused potentials of the human mind.<ref>A. Weil, W. Rosen. (1993), ''From Chocolate To Morphine: Everything You Need To Know About Mind-Altering Drugs''.New York, Houghton Mifflin Company. p. 93</ref><ref>Erowid. (1998, August 9). Erowid Humphry Osmond Vault. Retrieved from https://erowid.org/culture/characters/osmond_humphry/osmond_humphry.shtml</ref> It was on this term that Osmond eventually settled, because it was "clear, euphonious and uncontaminated by other associations."<ref>{{cite news |first= Douglas |last= Martin|coauthors= |title= Humphry Osmond, 86, Who Sought Medicinal Value in Psychedelic Drugs, Dies|url= https://www.nytimes.com/2004/02/22/us/humphry-osmond-86-who-sought-medicinal-value-in-psychedelic-drugs-dies.html?pagewanted=2|work= [[New York Times]]|publisher= |date= 2004-02-22|accessdate=4 December 2010 }}</ref> This mongrel spelling of the word "psychedelic" was loathed by American ethnobotanist Richard Evans Schultes, but championed by Timothy Leary, who thought it sounded better.<ref>W. Davis (1996), ''One River: Explorations and Discoveries in the Amazon Rain Forest''. New York, [[Simon & Schuster]], Inc. p. 120</ref> | ||
Due to the expanded use of the term "psychedelic" in pop culture and a perceived incorrect verbal formulation, Carl A.P. Ruck, Jeremy Bigwood, Danny Staples, [[Jonathan Ott]], and [[R. Gordon Wasson]] later proposed the term "[[entheogen]]" to describe the religious or spiritual experience produced by such substances.<ref>[[R. Gordon Wasson]], [[Albert Hofmann]], and Carl A.P. Ruck, ''The Road to Eleusis: Unveiling the Secret of the Mysteries'' (North Atlantic Books, 2008), pgs. 138-139</ref> | Due to the expanded use of the term "psychedelic" in pop culture and a perceived incorrect verbal formulation, Carl A.P. Ruck, Jeremy Bigwood, Danny Staples, [[Jonathan Ott]], and [[R. Gordon Wasson]] later proposed the term "[[entheogen]]" to describe the religious or spiritual experience produced by such substances.<ref>[[R. Gordon Wasson]], [[Albert Hofmann]], and Carl A.P. Ruck, ''The Road to Eleusis: Unveiling the Secret of the Mysteries'' (North Atlantic Books, 2008), pgs. 138-139</ref> | ||
Line 442: | Line 443: | ||
[[File:harmchart.png|thumb|right|315px|Radar plot showing relative physical harm, social harm, and dependence of LSD and psilocybin, which can tentatively be taken to apply psychedelics as a whole.<ref>Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a Rational Scale to Assess the Harm of Drugs of Potential Misuse, 1047–1053. http://dx.doi.org/10.1016/S0140-6736(07)60464-4</ref>]] | [[File:harmchart.png|thumb|right|315px|Radar plot showing relative physical harm, social harm, and dependence of LSD and psilocybin, which can tentatively be taken to apply psychedelics as a whole.<ref>Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a Rational Scale to Assess the Harm of Drugs of Potential Misuse, 1047–1053. http://dx.doi.org/10.1016/S0140-6736(07)60464-4</ref>]] | ||
While more research is needed, most psychedelics (and especially classical psychedelics) appear to be physiologically well-tolerated and have [[Toxicity::very low toxicity]] relative to dose.<ref name="nicholsPSY" /> Most psychedelics have very few physical side effects associated with acute exposure. Various studies have shown that, in reasonable doses in a sufficiently [[Set and setting|prepared context]], they are unlikely to present negative physical, cognitive, psychiatric or other toxic consequences. There is no evidence that classical psychedelics cause damage to any human body organ.<ref>Nichols, D. E. (2004). Hallucinogens. Pharmacology & Therapeutics, 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002</ref> However it should be noted that some exceptions exist, such as some members of the [[25x-NBOMe]], [[2C-T-x]], [[DOB]] and 5-MeO series. | |||
However, while psychedelics may not be capable of causing direct bodily harm or death, they can still have serious negative consequences. For example, they are capable of impairing the judgment and attention of users which may cause erratic or high-risk behaviors. In extreme cases, users may fall under the [[delusion]] that they are a character in a dream or physically invincible which may cause them to jump off of a building or run into a busy road.<ref name="Nichols2016"></ref> Additionally, intense negative experiences and psychotic episodes ([[bad trips|"bad trips"]]) can cause psychological trauma if not properly managed or treated. This is particularly a concern in non-[[trip sitter|supervised settings]] or when heavy doses are used. | |||
Psychedelics may trigger or exacerbate symptoms (e.g. [[delusions]], [[mania]], [[psychosis]]) in those who have or are predisposed to mental illness such as bipolar disorder or schizophrenia.<ref name="hallucinogens" /> Those with a personal or family history of mental illness (including anxiety and depression) should not use LSD without the advice of a qualified medical professional. | |||
===Lethal dosage=== | ===Lethal dosage=== | ||
Unlike many other illicit substances, psychedelics typically do not have established lethal dosages. There are no well-documented deaths attributable to the direct pharmacological action of any psychedelic, with the notable exception of the [[25x-NBOMe]], [[2C-T-x]], and 5-MeO series. | |||
===Dependence and abuse potential=== | ===Dependence and abuse potential=== | ||
Psychedelics are [[Addiction potential:: | Psychedelics are considered to have [[Addiction potential::low abuse potential]].<ref name="hallucinogens" /> There are no literature reports of successful attempts to train animals to self-administer psychedelics — an animal model predictive of abuse liability — indicating that it does not have the necessary pharmacology to either initiate or maintain dependence.<ref name="hallucinogens" /> Likewise, there is no human clinical evidence that psychedelics cause addiction. Finally, there is virtually no withdrawal syndrome when chronic use of these substances is stopped.<ref>Diaz, Jaime (1996). How Drugs Influence Behavior: A Neurobehavioral Approach. Englewood Cliffs: Prentice Hall. ISBN 9780023287640</ref> | ||
Tolerance to the effects of most psychedelics builds [[Time to full tolerance::almost immediately after ingestion]] and hits a peak once the effects wear off. After that, it takes about 5-7 days for the tolerance to be reduced to half and 1-2 weeks to be back at baseline (in the absence of further consumption). Most psychedelics present cross tolerance with [[cross-tolerance:: all [[psychedelics]]]], meaning they will have a reduced effect. | |||
Another exception includes psychedelic [[phenethylamines]] like [[2C-B]]. While the exact mechanism is not understood, generally tolerance is thought to rise immediately, but does not reach a peak unless with prolonged and repeated use. This means that the immediate tolerance does not rise as high as with [[lysergamides]] or [[tryptamines]] and can wear off faster and can be reduced to half within 1-2 days in the absence of further consumption. Mostly there will be less psychedelic and more stimulating effects. | Notable exceptions to this include [[DMT]] and related tryptamines like [[DPT]] and [[MET]], which are thought to produce little to no tolerance or cross-tolerance. Another exception includes psychedelic [[phenethylamines]] like [[2C-B]]. While the exact mechanism is not understood, generally tolerance is thought to rise immediately, but does not reach a peak unless with prolonged and repeated use. This means that the immediate tolerance does not rise as high as with [[lysergamides]] or [[tryptamines]] and can wear off faster and can be reduced to half within 1-2 days in the absence of further consumption. Mostly there will be less psychedelic and more stimulating effects. | ||
Extremely high doses of psychedelics can also produce a tolerance which can last a significantly longer time than expected. | Extremely high doses of psychedelics can also produce a tolerance which can last a significantly longer time than expected. |